Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levamisole for Tetanus Vaccination Response in Hemodialysis
NCT00705692Phase 2Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Mar 2008
- Primary completion
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Tetanus comparing Levamisole with Placebo (2 arms). Primary endpoint: Tetanus seroconversion rate at 6 months. Started Mar 2008; status: completed.
02
Drugs
levamisole
03
Conditions
Tetanus
Beyond the preview
Go deeper on NCT00705692.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00705692.